Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


04.03.2019

2 Indian Pediatr
4 J Infect Dis
1 J Pediatr
1 J Virol
1 JAMA
1 Lancet Oncol
1 MMWR Morb Mortal Wkly Rep
1 Pediatrics
3 PLoS One
1 Proc Natl Acad Sci U S A
17 Vaccine
1 Virus Res


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Indian Pediatr

  1. KUMAR CM, Bedi N
    Tuberculin Conversion after BCG Vaccination.
    Indian Pediatr. 2019;56:141-142.
    PubMed     Text format    

  2. THAKRE R, Patil PS
    Influenza Vaccine Paradox.
    Indian Pediatr. 2019;56:80.
    PubMed     Text format    


    J Infect Dis

  3. ITURRIZA-GOMARA M, Jere KC, Hungerford D, Bar-Zeev N, et al
    Aetiology of diarrhoea among hospitalised children in Blantyre, Malawi following rotavirus vaccine introduction: a case-control study.
    J Infect Dis. 2019 Feb 28. pii: 5366554. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. BARANIAK I, Kern F, Holenya P, Griffiths P, et al
    Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients.
    J Infect Dis. 2019 Feb 27. pii: 5366424. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. ANYWAINE Z, Whitworth H, Kaleebu P, Praygod G, et al
    Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania.
    J Infect Dis. 2019 Feb 23. pii: 5364034. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. MUTUA G, Anzala O, Luhn K, Robinson C, et al
    Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya.
    J Infect Dis. 2019 Feb 23. pii: 5364047. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  7. TOLTZIS P
    50 Years Ago in the Journal of Pediatrics: Oral Polio Immunization of the Newborn Infant; A Possible Method for Overcoming Interference by Ingested Antibodies.
    J Pediatr. 2018;199:177.
    PubMed     Text format    


    J Virol

  8. PALLETT MA, Ren H, Zhang RY, Scutts SR, et al
    Vaccinia virus BBK E3 ligase adaptor A55 targets importin-dependent NF-kappaB activation and inhibits CD8(+) T-cell memory.
    J Virol. 2019 Feb 27. pii: JVI.00051-19. doi: 10.1128/JVI.00051.
    PubMed     Text format     Abstract available


    JAMA

  9. ABU-RAYA B, Edwards KM
    Optimizing the Timing of Vaccine Administration During Pregnancy.
    JAMA. 2019 Feb 25. pii: 2726862. doi: 10.1001/jama.2019.0703.
    PubMed     Text format    


    Lancet Oncol

  10. SIMMS KT, Steinberg J, Caruana M, Smith MA, et al
    Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Lancet Oncol. 2019 Feb 19. pii: S1470-2045(18)30836.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  11. WOODRING J, Pastore R, Brink A, Ishikawa N, et al
    Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:195-200.
    PubMed     Text format     Abstract available


    Pediatrics


  12. Martinon-Torres F, Bernatowska E, Shcherbina A, et al. Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function. Pediatrics. 2018;142(3):e20174250.
    Pediatrics. 2019 Feb 28. pii: peds.2018-3836. doi: 10.1542/peds.2018-3836.
    PubMed     Text format    


    PLoS One

  13. SARAIVA MMS, Moreira Filho ALB, Freitas Neto OC, Silva NMV, et al
    Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut.
    PLoS One. 2018;13:e0203158.
    PubMed     Text format     Abstract available

  14. PILKERTON CS, Hobbs GR, Lilly C, Knox SS, et al
    Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy.
    PLoS One. 2018;13:e0203330.
    PubMed     Text format     Abstract available

  15. TUMIOTTO C, Alves BM, Recordon-Pinson P, Jourdain M, et al
    Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
    PLoS One. 2019;14:e0212347.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. NEIDEL S, Ren H, Torres AA, Smith GL, et al
    NF-kappaB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-kappaB activation.
    Proc Natl Acad Sci U S A. 2019 Feb 28. pii: 1813504116.
    PubMed     Text format     Abstract available


    Vaccine

  17. MUNYAKA PM, Kommadath A, Fouhse J, Wilkinson J, et al
    Characterization of whole blood transcriptome and early-life fecal microbiota in high and low responder pigs before, and after vaccination for Mycoplasma hyopneumoniae.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30211.
    PubMed     Text format     Abstract available

  18. WALKER EJ, MacDonald NE, Islam N, Le Saux N, et al
    Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review.
    Vaccine. 2019 Feb 25. pii: S0264-410X(19)30226.
    PubMed     Text format     Abstract available

  19. LEFEVRE H, Samain S, Ibrahim N, Fourmaux C, et al
    HPV vaccination and sexual health in France: Empowering girls to decide.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30215.
    PubMed     Text format     Abstract available

  20. MO Z, Ma X, Luo P, Mo Y, et al
    Immunogenicity of pentavalent rotavirus vaccine in Chinese infants.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30213.
    PubMed     Text format     Abstract available

  21. ABUBAKAR A, Melhem N, Malik M, Dbaibo G, et al
    Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.
    Vaccine. 2019 Feb 19. pii: S0264-410X(19)30163.
    PubMed     Text format     Abstract available

  22. HARRO C, Louis Bourgeois A, Sack D, Walker R, et al
    Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30220.
    PubMed     Text format     Abstract available

  23. PARVEEN N, Fernandez MC, Haynes AM, Zhang RL, et al
    Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30217.
    PubMed     Text format     Abstract available

  24. HAPPE M, Samuvel DJ, Ohtola JA, Korte JE, et al
    Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30182.
    PubMed     Text format     Abstract available

  25. WANG Z, Li Z, Su X, Qiao Y, et al
    Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30206.
    PubMed     Text format     Abstract available

  26. MIKAMO H, Yamagishi Y, Murata S, Yokokawa R, et al
    Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30154.
    PubMed     Text format     Abstract available

  27. KENNEDY RB, Ovsyannikova IG, Thomas A, Larrabee BR, et al
    Differential durability of immune responses to measles and mumps following MMR vaccination.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30225.
    PubMed     Text format     Abstract available

  28. DOENER F, Hong HS, Meyer I, Tadjalli-Mehr K, et al
    RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.
    Vaccine. 2019 Feb 21. pii: S0264-410X(19)30219.
    PubMed     Text format     Abstract available

  29. PERDRIZET JA, Shiau DS, Xie H
    The serological response in dogs inoculated with canine distemper virus vaccine at the acupuncture point governing vessel-14: A randomized controlled trial.
    Vaccine. 2019 Feb 21. pii: S0264-410X(18)31463.
    PubMed     Text format     Abstract available

  30. GETAHUN D, Fassett MJ, Peltier MR, Takhar HS, et al
    Association between seasonal influenza vaccination with pre- and postnatal outcomes.
    Vaccine. 2019 Feb 21. pii: S0264-410X(19)30214.
    PubMed     Text format     Abstract available

  31. KROGSGAARD LW, Bech BH, Plana-Ripoll O, Thomsen RW, et al
    Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study.
    Vaccine. 2019 Feb 22. pii: S0264-410X(19)30224.
    PubMed     Text format     Abstract available

  32. DOLAN SB, Carnahan E, Shearer JC, Beylerian EN, et al
    Redefining vaccination coverage and timeliness measures using electronic immunization registry data in low- and middle-income countries.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30212.
    PubMed     Text format     Abstract available

  33. HUANG LM, Chiu CH, Chiu NC, Lin CY, et al
    Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
    Vaccine. 2019 Feb 22. pii: S0264-410X(19)30218.
    PubMed     Text format     Abstract available


    Virus Res

  34. LIU F, Li L, Liu Y, Sun C, et al
    Development of reverse genetics system for small ruminant morbillivirus: Rescuing recombinant virus to express Echinococcus granulosus EG95 antigen.
    Virus Res. 2019;261:50-55.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: